Mayne Pharma reported $228.9M in Current Liabilities for its second fiscal semester of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Current Liabilities Change
Ansell ANN:AU $ 367M 182.9M
Cochlear COH:AU $ 377.6M 24.9M
CSL CSL:AU $ 2.52B 579.5M
Ecofibre Ltd EOF:AU 7.08M 1.37M
Healius Ltd HLS:AU $ 689.8M 5.1M
Integral Diagnostics Ltd IDX:AU 85.89M 7.99M
Nanosonics Ltd NAN:AU $ 19.81M 268K
Next Science Ltd NXS:AU 1.54M 38.07K
Polynovo Ltd PNV:AU 8.65M 2.13M
Probiotec Ltd PBP:AU 49.3M 4.87M
Ramsay Health Care RHC:AU $ 3.31B 406.6M
ResMed RMD:AU $ 667.26M 46.2M
Sigma Healthcare Ltd SIG:AU 457.61M 72.01M
Sonic Healthcare SHL:AU $ 2B 220.52M
Telix Pharmaceuticals Ltd TLX:AU 37.98M 15.69M